Search

Now showing items 1-10 of 20

Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker.

Winfield, JM; Wakefield, JC; Dolling, D; Hall, M; Freeman, S; et al. (2019-11)

Background Treatment of advanced epithelial ovarian cancer results in a relapse rate of 75%. Early markers of response would enable optimization of management and improved outcome in both primary and recurrent disease. ...

Erratum to: Prevalence and impact of severe fatigue in adolescent and young adult cancer patients in comparison with population-based controls.

Poort, H; Kaal, SEJ; Knoop, H; Jansen, R; Prins, JB; et al. (2017-09)

The UK plasma based molecular profiling of advanced breast cancer to inform therapeutic choices (plasmamatch) trial: a multiple parallel cohort, open-label, multi-centre phase IIa clinical trial aiming to provide proof of principle efficacy for designated targeted therapies in patients with advanced breast cancer where the targetable mutation is identified through ctDNA screening (CRUK/15/010)

Bliss, J; Kernaghan, S; Fribbens, C; Stevenson, L; Morden, J; et al. (BIOMED CENTRAL LTD, 2017-05-08)

Pixantrone: a novel anthracycline-like drug for the treatment of non-Hodgkin lymphoma

(2015-04)

Introduction: The current treatment approach of high-grade non-Hodgkin lymphoma (NHL) relies to a large extent on anthracycline-based regimens yielding cure rates in similar to 65 - 75% of patients. Despite being highly ...

PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer.

Ghaneh, P; Hanson, R; Titman, A; Lancaster, G; Plumpton, C; et al. (2018-02)

Background Pancreatic cancer diagnosis and staging can be difficult in 10-20% of patients. Positron emission tomography (PET)/computed tomography (CT) adds precise anatomical localisation to functional data. The use of ...

A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients with Advanced Solid Malignancies.

Juric, D; de Bono, JS; LoRusso, PM; Nemunaitis, J; Heath, EI; et al. (2017-09)

Purpose: To evaluate the safety, MTD, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of TAK-117 (MLN1117/INK1117), an investigational PI3Kα-selective inhibitor, in patients with advanced solid tumors. ...

Contribution of Common SNPs to Variability in Late Radiation Therapy Toxicity in Prostate Cancer

Kerns, S; Hao, K; Stahl, E; Rosenstein, BS; CaamaNo, AG; et al. (ELSEVIER SCIENCE INC, 2017-10-01)

BASELINE CIRCULATING TUMOR CELL COUNTS SIGNIFICANTLY ENHANCE A PROGNOSTIC SCORE FOR PATIENTS PARTICIPATING IN PHASE I ONCOLOGY TRIALS

Baird, RD; Sandhu, S; Yap, T; Massard, C; Papadatos-Pastos, D; et al. (OXFORD UNIV PRESS, 2011-05-01)

Effect of Dose to the Penile Bulb on Erectile Potency (EP) in Prostate Image-guided Radiotherapy (IGRT)

Murray, J; Dean, J; Mossop, H; Hall, E; Dearnaley, D; et al. (ELSEVIER SCIENCE LONDON, 2017-03-01)

Do Routine Computed Tomography Scans Detect Early Spinal Cord Compression in Patients with Castrate Resistant Prostate Cancer? Implications for the PROMPTS Trial

Khan, A; Gao, A; Hall, E; Hassan, S; Cruikshank, C; et al. (ELSEVIER SCIENCE LONDON, 2017-03-01)

Publications Repository

Publications Repository

Search

Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker.

Erratum to: Prevalence and impact of severe fatigue in adolescent and young adult cancer patients in comparison with population-based controls.

Pixantrone: a novel anthracycline-like drug for the treatment of non-Hodgkin lymphoma

PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer.

A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients with Advanced Solid Malignancies.

Contribution of Common SNPs to Variability in Late Radiation Therapy Toxicity in Prostate Cancer

BASELINE CIRCULATING TUMOR CELL COUNTS SIGNIFICANTLY ENHANCE A PROGNOSTIC SCORE FOR PATIENTS PARTICIPATING IN PHASE I ONCOLOGY TRIALS

Effect of Dose to the Penile Bulb on Erectile Potency (EP) in Prostate Image-guided Radiotherapy (IGRT)

Do Routine Computed Tomography Scans Detect Early Spinal Cord Compression in Patients with Castrate Resistant Prostate Cancer? Implications for the PROMPTS Trial

Search

Filters

Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker.

Erratum to: Prevalence and impact of severe fatigue in adolescent and young adult cancer patients in comparison with population-based controls.

Pixantrone: a novel anthracycline-like drug for the treatment of non-Hodgkin lymphoma

PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer.

A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients with Advanced Solid Malignancies.

Contribution of Common SNPs to Variability in Late Radiation Therapy Toxicity in Prostate Cancer

BASELINE CIRCULATING TUMOR CELL COUNTS SIGNIFICANTLY ENHANCE A PROGNOSTIC SCORE FOR PATIENTS PARTICIPATING IN PHASE I ONCOLOGY TRIALS

Effect of Dose to the Penile Bulb on Erectile Potency (EP) in Prostate Image-guided Radiotherapy (IGRT)

Do Routine Computed Tomography Scans Detect Early Spinal Cord Compression in Patients with Castrate Resistant Prostate Cancer? Implications for the PROMPTS Trial